Indivior Pharmaceuticals (INDV) Other Operating Expenses (2024 - 2025)
Historic Other Operating Expenses for Indivior Pharmaceuticals (INDV) over the last 3 years, with Q1 2025 value amounting to -$1.0 million.
- Indivior Pharmaceuticals' Other Operating Expenses changed N/A to -$1.0 million in Q1 2025 from the same period last year, while for Jun 2025 it was -$36.0 million, marking a year-over-year increase of 7662.34%. This contributed to the annual value of -$195.0 million for FY2024, which is 1841.0% up from last year.
- Per Indivior Pharmaceuticals' latest filing, its Other Operating Expenses stood at -$1.0 million for Q1 2025.
- Over the past 5 years, Indivior Pharmaceuticals' Other Operating Expenses peaked at $6.0 million during Q4 2023, and registered a low of -$160.0 million during Q2 2024.
- Moreover, its 3-year median value for Other Operating Expenses was -$1.0 million (2025), whereas its average is -$38.0 million.
- Data for Indivior Pharmaceuticals' Other Operating Expenses shows a peak YoY increase of 8333.33% (in 2024) and a maximum YoY decrease of 8333.33% (in 2024) over the last 5 years.
- Over the past 3 years, Indivior Pharmaceuticals' Other Operating Expenses (Quarter) stood at $6.0 million in 2023, then tumbled by 83.33% to $1.0 million in 2024, then crashed by 200.0% to -$1.0 million in 2025.
- Its Other Operating Expenses stands at -$1.0 million for Q1 2025, versus $1.0 million for Q4 2024 and -$36.0 million for Q3 2024.